1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.
(
- Contribution to journal › Article
- 2002
-
Mark
Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.
(
- Contribution to journal › Article